ARIAD Pharmaceuticals, Inc. (NASDAQ: ARIA) today announced that its Annual Meeting of Stockholders will be webcast live on June 21, 2012 and can be accessed by visiting the investor relations section of the Company's website at http://www.ariad.com/investor.

The annual meeting will take place at 10:00 a.m. (EDT) at the Company's offices in Cambridge, Massachusetts and will include an overview of ARIAD and its key programs provided by Harvey J. Berger, M.D., chairman and chief executive officer of ARIAD, and key members of senior management. A replay will be available on the investor page of the ARIAD website approximately three hours after the presentation and will be archived for four weeks. To ensure a timely connection to the live webcast, participants should log on at least fifteen minutes prior to the scheduled start time.

About ARIAD

ARIAD Pharmaceuticals, Inc. is an emerging global oncology company focused on the discovery, development and commercialization of medicines to transform the lives of cancer patients. ARIAD’s approach to structure-based drug design has led to several internally discovered, molecularly targeted product candidates for drug-resistant or difficult-to-treat cancers, including certain forms of chronic myeloid leukemia and non-small cell lung cancer. For additional information, visit http://www.ariad.com or follow ARIAD on Twitter (@ARIADPharm).